In this Issue:
Intracoronary CD34+-cell injections in chronic ischaemic HF
HF and risk of diabetes
CPAP effects on cardiac efficiency in HF with OSA
Intestinal blood flow in HF: links with bacteria, GI symptoms and cachexia
Worsening renal function in HFPEF and impact of irbesartan
Prognostic value of NT-proCNP in HFPEF/HFREF
Baroreflex activation in HF
Systolic BP and outcomes in elderly HF treated with nebivolol
Spironolactone and 30-day death and HF rehospitalisation
Long-term survival in acute decompensated HF according to EF
Please login below to download this issue (PDF)